NCT04895748 2026-03-03DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other MalignanciesNovartisPhase 1 Terminated40 enrolled
NCT03001349 2021-02-1568Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Terminated4 enrolled